Reviews PlasmaLyte A


No reviews yet.

PlasmaLyte A Drug Description
PLASMA-LYTE A
Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)
is a sterile, nonpyrogenic isotonic solution in a single dose container for
intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride,
USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7);
368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O);
37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP
(MgCl2•6H2O). It contains no antimicrobial agents. The
pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a sousrce of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate, and 23 mEq gluconate. The osmolarity is 294 mOsmol/L (calc). Normal physiologic osmolarity range is 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions may cause vein damage. The caloric content is 21 lcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/30/2008




PlasmaLyte A Drug Description
PLASMA-LYTE A
Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)
is a sterile, nonpyrogenic isotonic solution in a single dose container for
intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride,
USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7);
368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O);
37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP
(MgCl2•6H2O). It contains no antimicrobial agents. The
pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a sousrce of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate, and 23 mEq gluconate. The osmolarity is 294 mOsmol/L (calc). Normal physiologic osmolarity range is 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions may cause vein damage. The caloric content is 21 lcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/30/2008




PlasmaLyte A Drug Description
PLASMA-LYTE A
Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)
is a sterile, nonpyrogenic isotonic solution in a single dose container for
intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride,
USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7);
368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O);
37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP
(MgCl2•6H2O). It contains no antimicrobial agents. The
pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a sousrce of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate, and 23 mEq gluconate. The osmolarity is 294 mOsmol/L (calc). Normal physiologic osmolarity range is 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions may cause vein damage. The caloric content is 21 lcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/30/2008




PlasmaLyte A Drug Description
PLASMA-LYTE A
Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)
is a sterile, nonpyrogenic isotonic solution in a single dose container for
intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride,
USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7);
368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O);
37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP
(MgCl2•6H2O). It contains no antimicrobial agents. The
pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a sousrce of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate, and 23 mEq gluconate. The osmolarity is 294 mOsmol/L (calc). Normal physiologic osmolarity range is 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions may cause vein damage. The caloric content is 21 lcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/30/2008




PlasmaLyte A Drug Description
PLASMA-LYTE A
Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) in AVIVA Plastic
Container
DRUG DESCRIPTION
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP)
is a sterile, nonpyrogenic isotonic solution in a single dose container for
intravenous administration. Each 100 mL contains 526 mg of Sodium Chloride,
USP (NaCl); 502 mg of Sodium Gluconate (C6H11NaO7);
368 mg of Sodium Acetate Trihydrate, USP (C2H3NaO2•3H2O);
37 mg of Potassium Chloride, USP (KCl); and 30 mg of Magnesium Chloride, USP
(MgCl2•6H2O). It contains no antimicrobial agents. The
pH is adjusted with sodium hydroxide. The pH is 7.4 (6.5 to 8.0).
PLASMA-LYTE A Injection pH 7.4 (Multiple Electrolytes Injection, Type 1, USP) administered intravenously has value as a sousrce of water, electrolytes, and calories. One liter has an ionic concentration of 140 mEq sodium, 5 mEq potassium, 3 mEq magnesium, 98 mEq chloride, 27 mEq acetate, and 23 mEq gluconate. The osmolarity is 294 mOsmol/L (calc). Normal physiologic osmolarity range is 280 to 310 mOsmol/L. Administration of substantially hypertonic solutions may cause vein damage. The caloric content is 21 lcal/L.
The flexible container is made with non-latex plastic materials specially designed for a wide range of parenteral drugs including those requiring delivery in containers made of polyolefins or polypropylene. For example, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of paclitaxel. In addition, the AVIVA container system is compatible with and appropriate for use in the admixture and administration of all drugs deemed compatible with existing polyvinyl chloride container systems. The solution contact materials do not contain PVC, DEHP, or other plasticizers.
The suitability of the container materials has been established through biological evaluations, which have shown the container passes Class VI U.S. Pharmacopeia (USP) testing for plastic containers. These tests confirm the biological safety of the container system.
The flexible container is a closed system, and air is prefilled in the container to facilitate drainage. The container does not require entry of external air during administration.
The container has two ports: one is the administration outlet port for attachment
of an intravenous administration set and the other port has a medication site
for addition of supplemental medication (See Directions
for Use). The primary function of the overwrap is to protect the container
from the physical environment.Last reviewed on RxList: 12/30/2008





Other reviews about PlasmaLyte A on wordpress

Bellie improves (still not out of woods, though)
  by fromtheworldofpmg
src=\"http://pmgwlu.files.wordpress.com/2009/05/1154714180-hr-49.jpg\" Well, Dr Worthington is stunned.  That is the word he used. Yesterday afternoon, Dr Kunde said he would have been ok with Bellie\'s BUN coming down to the […]


General Surgery Rotation
  by ucsfstudents
General Surgery Rotation [youtube=http://www.youtube.com/watch?v=4Txi6CPe46Y&feature=related] This is a video from Scrubs, reflecting on the image of the surgeon. Enjoy it while you read the comments. And please post your own advice […]



Other reviews about PlasmaLyte A on web:

Learn about the prescription medication PlasmaLyte A (Multiple Electrolytes Injection), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. PlasmaLyte A (Multiple Electrolytes Injection) Drug Information ...


Plasmalyte as a Cause of False-Positive Results for Aspergillus Galactomannan in Bronchoalveolar Lavage Fluid Plasmalyte as a Cause of False-Positive Results for Aspergillus ...


This information may not cover all possible uses, directions, side effects, precautions, allergic reactions, drug interactions, or withdrawal times. Normosol-R/Isolyte-S/Plasmalyte A


Indications for use, precautions, side effects, dose, food or drug interactions, contraindications, toxicity, and signs of an overdose of Normosol-R, Isolyte-S, or Plasmalyte A ... The Veterinary Use of Normosol-R, Isolyte-S, & Plasmalyte A in Pets


The newest energy drink. YouTube - Plasmalyte A


PLASMA-LYTE (Electrolyte) Replenishment Solutions in VIAFLEX Plastic Container Baxter US Product Catalog - PLASMA-LYTE (Electrolyte ...


1. Anaesthesia. 1994 Sep;49(9):779-81. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative ...


In fact, her institution 'provided proof' that the FDA has approved addition of Plasmalyte to blood to AABB inspectors during a past inspection. CBBS: Which solutions other than isotonic saline are approved for ...


Plasmalyte A: resuscitation fluid; contains sodium, potassium, chlorides, calcium, magnesium & bicarbonates Plasmalyte A Summary Report | CureHunter


We are a value-added service provider and distributor of pharmaceuticals, medical supplies and equipment to animal hospitals and Veterinarians since 1946. Our business is committed ... Webster Veterinary - plasmalyte a 1000ml bag ca14





Featured Reviews

Reviews Tracrium

Tracrium Drug Description DRUG DESCRIPTION TRACRIUM (atracurium besylate) is an intermediate-duration, nondepolarizing, skeletal muscle relaxant for intravenous administration. Atracurium besylate is designated as 2,2'-[1,5-pentanediylbis[oxy(3-ox...
Read More  |  Review This
Reviews Olux

Olux Drug Description Olux (clobetasol propionate) Foam, 0.05% For Dermatologic Use Only Not for Ophthalmic Use DRUG DESCRIPTION What are the possible side effects of clobetasol topical? Get emergency medical help if you have...
Read More  |  Review This
Reviews Alprazolam

Niravam Drug Description NIRAVAM™ (alprazolam orally disintegrating) Tablets DRUG DESCRIPTION What are the possible side effects of alprazolam (Niravam, Xanax, Xanax XR)? Get emergency medical help if you have any of these...
Read More  |  Review This
Reviews Human Analog)

Humalog Drug Description HUMALOG® (insulin lispro, rDNA origin) injection 100 Units Per ML (U-100) DRUG DESCRIPTION What are the possible side effects of insulin lispro (Humalog, Humalog Cartridge, Humalog KwikPen, Humalog...
Read More  |  Review This
Reviews Vidarabine

Vira-A Drug Description VIRA-A (vidarabine monohydrate) Ointment DRUG DESCRIPTION What are the possible side effects of vidarabine ophthalmic (Vira-A)? Serious side effects are not expected to occur with the use of this medication. Commonly...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....